Bremelanotide acetate is primarily used in the medical field to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It works by activating melanocortin receptors in the brain, which helps to enhance sexual desire and reduce distress associated with low libido. The drug is administered as a subcutaneous injection, typically taken on an as-needed basis, about 45 minutes before anticipated sexual activity. Its application provides a therapeutic option for women who experience a significant decrease in sexual desire, improving their quality of life and sexual satisfaction. Bremelanotide acetate is not intended for continuous daily use but rather for occasional use to address specific episodes of sexual activity.